@saskcancer.bsky.social

🚨 Reminder to register for our upcoming LIVE session:

Common Sense Oncology. Spring Cleaning: The Evidence from ASH 2025. Tuesday, March 24, 2026, 4-5 pm EDT. Drs. Bernard Marini, Anthony Perissinotti, Manni Mohyuddin, Eddie Cliff, Roberta Demichelis.

Missed CSO’s latest journal club? Check out the recording of "Spring Cleaning: The Evidence from ASH 2025” for critical appraisals of hematology studies presented at ASH.

Watch now: youtu.be/XACCvhLqP2c

#CommonSenseOncology #CancerCare

Common Sense Oncology 2026 Leadership Meeting Plenary Keynotes. Tuesday, April 14, 2026 from 3:40 to 5:15 pm Eastern Daylight Time. Three panelist profiles with talk titles and biographic details. From left to right: Human Crisis in Cancer by Dr. Richard Sullivan, Institute of Cancer Policy, King's College London; Cancer Policy in Rwanda by Dr. Fidel Rubagumya, Rwanda Military Teaching Hospital, University of Rwanda; Good Pharma Scorecard by Dr. Jennifer Miller, Program for Biomedical Ethics, Yale School of Medicine. Scannable QR code to go to Zoom registration online.

Join us LIVE online on April 14 at 3:40 pm (EDT) for the Open Plenary Session of the Common Sense Oncology Leadership Meeting with Keynote Speakers Drs. Richard Sullivan, Fidel Rubagumya, and Jennifer Miller!

Register here: tinyurl.com/n2n7572c

#CommonSenseOncology #CancerCare

This is your reminder to register for tomorrow’s webinar!

#CommonSenseOncology #CancerCare

Spring Cleaning: The Evidence from ASH 2025. March 24, 2026 at 4 pm ET. Panelists: Dr. Bernie Martini, Dr. Anthony Perissinotti, Dr. Manni Mohyuddin, Dr. Eddie Cliff, Dr. Roberta Demichelis.

Join Common Sense Oncology's global hematology panel for a look back at the highlights from the American Society of Hematology's 2025 annual meeting.

Register today to save your spot over Zoom on March 24th, 2026 at 4 pm ET. See you there!

tinyurl.com/2mmvb5ye

#CommonSenseOncology #CancerCare

Oncology in the Pacific: Common Sense Oncology Pacific Hub. Prof. Christopher Jackson, Dr. Deme Karikios, Prof. Lorraine Chantrill, and Dr. Samuel Stevens.

The inaugural Common Sense Oncology Pacific Hub webinar, which took place on February 26th, was a success! In case you missed it or want to watch the recording, access it here:

tinyurl.com/z9futpsc

#CommonSenseOncology #CancerCare

Text reads: Navigating a cancer diagnosis is complex. 10 minutes of your time could help empower patients. Pictured: a doctor provides care to a patient. Common Sense Oncology, Queen’s University, and CDA-AMC logos.

Are you an oncologist, caregiver, patient, or patient advocate? Take 10 minutes to help empower future patients to have the information they need for decision-making by filling out this survey: tinyurl.com/ywxmms4u

#CommonSenseOncology #CancerCare

Common Sense Oncology Pacific Hub. Inaugural Webinar: Thursday, February 26, 2026, at 5 pm AWDT / 7 pm AEDT / 9 pm NZT. Featured speakers: Dr. Deme Karikios, Nepean Hospital; Dr. Samuel Stevens, Common Sense Oncology; Prof. Christopher Jackson, Mercy Hospital. Learn about the challenges and opportunities in oncology in the Pacific and discuss how CSO can better serve the needs of your region.

Join us for the Common Sense Oncology Pacific Hub!

Taking place Thursday, February 26 at 5 pm AWDT / 7 pm AEDT / 9 pm NZT, discuss the challenges and opportunities in oncology in the Pacific and how CSO can better serve the needs of the region.

Register: tinyurl.com/us5vbct9

#CancerCare

(2/2) This will help ensure that readers are able to make well-informed clinical decisions in the best interest of patients.

Read The Lancet Oncology’s full Comment and new editorial guidelines: tinyurl.com/4nztpej3

@thelancetoncol.bsky.social #CommonSenseOncology #CancerCare

The Lancet Oncology logo with a screenshot of the Comment title: Greater transparency for oncology clinical trials reporting. Authors: David Collingridge, Allison Landman, Robert Brierley, Claudia Schaefer, Jie Cai, Emma Grainger, Sonia Muliyil, Lan-Lan Smith.

(1/2) In an important development for the oncology community, The Lancet Oncology & other Lancet family specialty journals are adopting new rigorous standards for clinical trials reporting, consistent with the CSO Checklist.

@thelancetoncol.bsky.social #CommonSenseOncology #CancerCare

ALASCCA Trial | Common Sense Oncology India Hub - Journal Club YouTube video by Common Sense Oncology

Can aspirin be used in the treatment of colorectal cancers?

Listen to the critical appraisal of the ALASCCA Trial by Common Sense Oncology India Hub, featuring experts Dr. Teena Rajan, Dr. Omshree Shetty, & Prof. Ruth Langley.

www.youtube.com/watch?v=2qmC...

#CommonSenseOncology #CancerCare

Youtube thumbnail for this podcast episode. The Human Crisis in Cancer Care by Common Sense Oncology. Dr. Richard Sullivan, the episode guest speaker, smiles. The podcast icon, a stethoscope, is faded in the background.

In this inaugural episode of the Common Sense Oncology Podcast, hear from Dr. Richard Sullivan about the recently published Lancet Oncology Commission on the Human Crisis in Cancer Care.

Listen now:

YT: tinyurl.com/4tar52n4
🍎: tinyurl.com/yn5k9n8b
Sp: tinyurl.com/yj8pk6xf

Common Sense Oncology India Hub: Journal Club: ALASCCA Trial. Wednesday, January 21, 2026, 7-8 pm (IST). Featured speakers: Dr. Teena Rajan, Prof. Ruth Langley, Dr. Omshree Shetty.

Join us on Wednesday, January 21, 2026, at 7:00 pm India Standard Time to learn more about CSO and discuss a critical appraisal of the ALASCCA trial (low dose aspirin for colon cancer trial).

Register now: tinyurl.com/4uxxk77e

#110 Dec 2025. ISSN: 2036-9468. CancerWorld. Common Sense Oncology: Putting Patients Back at the Center in the Era of Cancer Innovation. By Adriana Albini.

Have you seen the Dec issue of Cancer World's magazine? This release features an article about CSO explaining the paradox of progress in cancer medicines & care, the Common Sense Oncology movement, & what defines meaningful benefit.

▶️ Read it on pg 38: tinyurl.com/bdd76yu4

#CommonSenseOncology

The Lancet Oncology. Title: the Human Crisis in Cancer. List of authors.

🚨 CSO was highlighted in the newly released Lancet Oncology Commission, "The Human Crisis in Cancer". This important paper identifies the growing imbalance between technical advances & the human dimensions in cancer care.

Read: tinyurl.com/555cefsj

@thelancetoncol.bsky.social #CancerCare

Common Sense Oncology at London Global Cancer Week. Delivering Outcomes that Matter to Patients. Monday, November 24th, 2025, 6:00 - 7:00 pm GMT. Speakers, from left to right: Professor Ian Tannock, Princess Margaret Hospital, University of Toronto; Dr. Haydee Verduzco-Aguirre, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán; Dr. Brooke Wilson, Kingston Health Sciences Centre, Queen's University; Dr. Michelle Tregear, National Breast Cancer Coalition; Professor Christopher Jackson, Mercy Hospital.

Mark your calendars for CSO's LGCW webinar on Nov 24th! Hear from our Working Group Leaders, Drs. Ian Tannock, Haydeé Verduzco-Aguirre, Brooke Wilson, Michelle Tregear, & Christopher Jackson about CSO’s exciting work & learn how to get involved.

tinyurl.com/3r9xdrx4

#LGCW2025 #CancerCare

Dr. Murphy and Dr. Gyawali pose for a picture as they conduct an interview about Common Sense Oncology.

In the latest episode of the GU Cast podcast, host & urologist Dr. Declan Murphy interviewed Dr. Bishal Gyawali about #CommonSenseOncology at the #ANZUP25 meeting in Sydney, Australia.

Watch: https://tinyurl.com/2jcktw4y
Listen: https://tinyurl.com/yy9urv63 

#CancerCare

Screenshot of the commentary title, journal logo, and CSO logo. The Lancet Oncology. Overall survival assessment in cancer drug trials: a luxury or a necessity? Common Sense Oncology.

Just published in @thelancetoncol.bsky.social, a commentary by CSO: Drs. Samuel Stevens, @lateuwen.bsky.social, & Bishal Gyawali commends & provides further recommendations to the FDA’s latest guidance on randomized cancer drug trials.

Read: tinyurl.com/2mzppf3p

#CommonSenseOncology #CancerCare

@winettevandergraaf.bsky.social @qol.eortc.org @rachriechelmann.bsky.social @madelinepe.bsky.social

CSO was at #ESMO2025 today, hosting a symposium to discuss our work in advancing patient-centred cancer care, and how best to engage colleagues and the broader community in Europe and beyond.

#CommonSenseOncology #CancerCare

Screenshot of the paper title, journal logo and information, and author byline. “While you are on chemotherapy…”: common recommendations that lack evidence and may cause harm. Common Sense Oncology logo.

Myth busting: is there evidence behind common precautions people take while on chemotherapy?

In this paper, CSO authors discuss evidence & examples of common precautionary recommendations patients receive during treatment.

Read it: doi.org/10.1093/jnci...

#CommonSenseOncology #CancerCare

Join us at the Messe Berlin for a special CSO symposium. Panelists, from left to right: Dr. Winette van der Graaf, Dr. Chris Booth, Dr. Madeline Pe, Dr. Dario Trapani, Dr. Rachel Riechelmann, Dr. Chris Cronin, and Dr. Samuel Stevens. Topics, from left to right: CSO and Clinical Trials, CSO Momentum, CSO and QOL, CSO and Education, CSO and Global Oncology, CSO-EORTC Fellowship, and CSO Fellowship. Location: ESMO Congress, Messe Berlin, Room Beta 7, HUB27 (Level Beta).

📅 Attending ESMO in Berlin? Don't miss this special CSO Symposium taking place on Fri Oct 17, 5:30-7:00 pm CET. 
Moderated by @winettevandergraaf.bsky.social, the panel will discuss recent CSO initiatives & activities in Europe & beyond.

See you there!

@eortc.org #CancerCare #CommonSenseOncology

Read the paper: tinyurl.com/mpxtrxw7

Read more about CSO principles for RCTs: tinyurl.com/yc4bat6a

#CommonSenseOncology #CancerCare

A screenshot of title and authors of the paper published in the European Journal of Cancer.

Congrats to former CSO Fellow Dr. Omar Abdihamid (first author)& collaborators for publishing a paper in the European Journal of Cancer evaluating 55 randomized clinical trials for adherence to the CSO’s principles for phase III cancer RCTs published earlier this year in @thelancetoncol.bsky.social.

Common Sense Oncology: CHALLENGE Journal Club with Dr. Chris Booth and Dr. Fernanda Arthuso. Logos for Canadian Cancer Trials Group, University of Alberta, Queen’s University, and Sinclair Cancer Research Institute.

▶️ Watch now: Dr. Chris Booth and Dr. Fernanda Arthuso discuss the CHALLENGE Trial, which found that structured exercise can be an effective adjuvant treatment for colon cancer.

tinyurl.com/yckbbcfn

#CommonSenseOncology #CancerCare #ColonCancer

Common Sense Oncology Virtual Journal Club. Profile images and title descriptions for lead authors. From left to right: Dr. Christopher Booth, Medical Oncologist at Queen’s University, Kingston, Canada; Dr. Fernanda Arthuso, Postdoctoral Researcher at University of Alberta, Edmonton, Canada. Canadian Cancer Trials Group and Common Sense Oncology logos.

Happening today—last chance to register! 🚨 Curious about how exercise can help treat colon cancer? Hear from Drs. Chris Booth & Fernanda Arthuso, authors of the trial, online today @ 12 pm EDT.

Register: https://tinyurl.com/462jujzu

#CommonSenseOncology #CancerCare

Common Sense Oncology at ESMO. CSO members gathering at last year’s event; a speaker at a podium addresses the seated audience. Join us in Berlin on October 17!

Join us at the Messe Berlin for a special CSO symposium. Panelists, from left to right: Dr. Winette van der Graaf, Dr. Chris Booth, Dr. Madeline Pe, Dr. Dario Trapani, Dr. Rachel Riechelmann, and Dr. Chris Cronin. Topics, from left to right: CSO and Clinical Trials, CSO Momentum, CSO and QOL, CSO and Education, CSO and Global Oncology, and CSO-EORTC Fellowship. Register now to receive location details.

📅 Attending ESMO in Berlin? Don't miss this special CSO Symposium taking place on Fri Oct 17, 5:30-7:00 pm CET. 

Moderated by @winettevandergraaf.bsky.social, the panel will discuss recent CSO initiatives & activities in Europe & beyond.
See you there!

@eortc.org #CancerCare #CommonSenseOncology

Pharma Is Pushing $200,000 Cancer Drugs When Cheaper Doses May Work Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — if pharmaceutical companies would allow it.

Bloomberg released an article highlighting efforts to reduce cancer drug doses while preserving outcomes & making treatments more affordable & accessible globally.

Read more: tinyurl.com/93n5xxvk

#CommonSenseOncology #CancerCare

The @eortc.org & @cancerpatientseu.bsky.social are advocating for a patient-centered approach to cancer care & research in Europe.

More: tinyurl.com/yc2n5kvc

#CommonSenseOncology #CancerCare